Cargando…
Inhaled Bacteriophage Therapy for Multi-Drug Resistant Achromobacter
The rise of antimicrobial resistant (AMR) bacteria is a global public health threat. AMR Achromobacter bacteria pose a challenging clinical problem, particularly for those with cystic fibrosis (CF) who are predisposed to chronic bacterial lung infections. Lytic bacteriophages (phages) offer a potent...
Autores principales: | Winzig, Franziska, Gandhi, Shiv, Lee, Alina, Würstle, Silvia, Stanley, Gail L., Capuano, Isabella, Neuringer, Isabel, Koff, Jonathan L., Turner, Paul E., Chan, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765334/ https://www.ncbi.nlm.nih.gov/pubmed/36568830 |
Ejemplares similares
-
A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections
por: Geyer, Jessica, et al.
Publicado: (2023) -
Identification and molecular characterization of bacteriophage phiAxp-2 of Achromobacter xylosoxidans
por: Li, Erna, et al.
Publicado: (2016) -
Characterization of Novel Lytic Bacteriophages of Achromobacter marplantensis Isolated from a Pneumonia Patient
por: Chan, Hiu Tat, et al.
Publicado: (2020) -
Salphage: Salvage Bacteriophage Therapy for Recalcitrant MRSA Prosthetic Joint Infection
por: Doub, James B., et al.
Publicado: (2022) -
Isolation and molecular characterisation of Achromobacter phage phiAxp-3, an N4-like bacteriophage
por: Ma, Yanyan, et al.
Publicado: (2016)